Drugs & TargetsFree Polaris Group’s lead product candidate, ADI-PEG 20 receives US and EU orphan designations January 09, 2015Vol.41 No.01
Drugs & TargetsFree Amgen and Kite Pharma entered into a strategic research collaboration January 09, 2015Vol.41 No.01
Drugs & TargetsFree FDA approved a supplemental biologics license application for Gazyva January 06, 2015Vol.41 No.01
Drugs & Targets FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza January 02, 2015Vol.37 No.12
Drugs & Targets CMS issues final payment decision for Cologuard screening test December 05, 2014Vol.40 No.45
Drugs & Targets Broad Institute, Harvard University, MIT and Editas Medicine form collaboration December 05, 2014Vol.40 No.45
